Nautilus Biotechnolgy, Inc. NAUT 深 沪
已收盘 10-09 16:00:00 美东时间
2.25
+0.430
+23.63%
华盛通- 最 高2.46
- 今 开1.93
- 成交量 1954.65万股
- 最 低 1.85
- 昨 收 1.82
- 总市值 2.86亿
- 52周最高 4.3101
- 市盈率 静 --
- 换手率 15.36%
- 52周最低 0.8411
- 委 比 17.51%
- 总股本 1.27亿
- 历史最高 12.38
- 量 比 1.32
- 振 幅 33.52%
- 历史最低 0.62
- 每 手 1
- 风险率 0.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股夜盘 | Nautilus Biotechnolgy, Inc.暴升15.31%，最新股价2.26美元
Nautilus Biotechnolgy, Inc.暴升15.31%，报2.26美元
10-05 08:01
美股大行评级 | 潜在涨幅11184.05%！如瑞迪博士获花旗上调目标价至1450美元，维持"买入"评级
今日重点评级关注：花旗：上调如瑞迪博士"买入"评级，目标价从1040美元升至1450美元；加拿大帝国商业银行：维持Inventiva"买入"评级，目标价从20美元升至21美元
09-30 08:33
Roth Capital Initiates Coverage On Nautilus Biotechnology with Buy Rating, Announces Price Target of $3.5
Roth Capital analyst Max Masucci initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Buy rating and announces Price Target of $3.5.
09-29 17:31
美股夜盘 | Nautilus Biotechnolgy, Inc.暴升15.59%，最新股价1.03美元
Nautilus Biotechnolgy, Inc.暴升15.59%，报1.03美元
09-16 12:29
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
Leerink Partners Initiates Coverage On Nautilus Biotechnology with Outperform Rating, Announces Price Target of $4
Leerink Partners analyst Puneet Souda initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Outperform rating and announces Price Target of $4.
09-09 23:20
Nautilus Biotechnology Q2 EPS $(0.11) Beats $(0.14) Estimate, Sales $190.000K
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported $190.000 thousand in sales ...
07-28 18:12
Top 3 Health Care Stocks That May Rocket Higher In July
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give...
07-06 18:11
Nautilus Biotechnology Reports Q1 2026 Results: Full Earnings Call Transcript
Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter financial results o...
04-28 21:20
Earnings Scheduled For April 28, 2026
Companies Reporting Before The Bell • LGI Homes (NASDAQ:LGIH) is likely to repo...
04-28 19:11
